3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Ovarian Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Urogenital Neoplasms
3
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Gastrointestinal Neoplasms
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Rectal Neoplasms
2
Multiple Myeloma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Interventions
Temozolomide
6
Specimen Handling
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
vocimagene amiretrorepvec
1
trametinib
1
olutasidenib
1
dabrafenib
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Outcome Assessment, Health Care
1
Observational Studies as Topic
1
Ketoconazole
1
Irinotecan
1
Heart Rate
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
DNA
1
Craniotomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
aldesleukin
×
90 days
×
Clear all
No trials found.